4//SEC Filing
NORTH BRIDGE VENTURE PARTNERS V-B LP 4
Accession 0000899243-23-014352
CIK 0001327273other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:15 PM ET
Size
28.4 KB
Accession
0000899243-23-014352
Insider Transaction Report
Form 4
Transactions
- Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+601,806$75,226→ 601,806 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (601,806 underlying) - Purchase
Common Stock
2023-05-31$2.43/sh+403,858$981,375→ 2,259,301 total(indirect: See footnote) - Purchase
Common Stock
2023-05-31$2.43/sh+1,203,612$2,924,777→ 2,521,745 total(indirect: See footnote) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+201,929$25,241→ 201,929 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (201,929 underlying) - Purchase
Common Stock
2023-05-31$2.43/sh+197,946$481,009→ 1,107,370 total(indirect: See footnote) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+98,973$12,372→ 98,973 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (98,973 underlying)
Transactions
- Purchase
Common Stock
2023-05-31$2.43/sh+403,858$981,375→ 2,259,301 total(indirect: See footnote) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+201,929$25,241→ 201,929 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (201,929 underlying) - Purchase
Common Stock
2023-05-31$2.43/sh+1,203,612$2,924,777→ 2,521,745 total(indirect: See footnote) - Purchase
Common Stock
2023-05-31$2.43/sh+197,946$481,009→ 1,107,370 total(indirect: See footnote) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+98,973$12,372→ 98,973 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (98,973 underlying) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+601,806$75,226→ 601,806 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (601,806 underlying)
NBVM GP, LLC
10% Owner
Transactions
- Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+201,929$25,241→ 201,929 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (201,929 underlying) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+98,973$12,372→ 98,973 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (98,973 underlying) - Purchase
Common Stock
2023-05-31$2.43/sh+197,946$481,009→ 1,107,370 total(indirect: See footnote) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+601,806$75,226→ 601,806 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (601,806 underlying) - Purchase
Common Stock
2023-05-31$2.43/sh+403,858$981,375→ 2,259,301 total(indirect: See footnote) - Purchase
Common Stock
2023-05-31$2.43/sh+1,203,612$2,924,777→ 2,521,745 total(indirect: See footnote)
DAMORE RICHARD A
10% Owner
Transactions
- Purchase
Common Stock
2023-05-31$2.43/sh+197,946$481,009→ 1,107,370 total(indirect: See footnote) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+98,973$12,372→ 98,973 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (98,973 underlying) - Purchase
Common Stock
2023-05-31$2.43/sh+403,858$981,375→ 2,259,301 total(indirect: See footnote) - Purchase
Common Stock
2023-05-31$2.43/sh+1,203,612$2,924,777→ 2,521,745 total(indirect: See footnote) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+201,929$25,241→ 201,929 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (201,929 underlying) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+601,806$75,226→ 601,806 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (601,806 underlying)
NORTH BRIDGE VENTURE PARTNERS V-B LP
10% Owner
Transactions
- Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+98,973$12,372→ 98,973 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (98,973 underlying) - Purchase
Common Stock
2023-05-31$2.43/sh+197,946$481,009→ 1,107,370 total(indirect: See footnote) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+201,929$25,241→ 201,929 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (201,929 underlying) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+601,806$75,226→ 601,806 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (601,806 underlying) - Purchase
Common Stock
2023-05-31$2.43/sh+403,858$981,375→ 2,259,301 total(indirect: See footnote) - Purchase
Common Stock
2023-05-31$2.43/sh+1,203,612$2,924,777→ 2,521,745 total(indirect: See footnote)
NORTH BRIDGE VENTURE PARTNERS V A LP
10% Owner
Transactions
- Purchase
Common Stock
2023-05-31$2.43/sh+403,858$981,375→ 2,259,301 total(indirect: See footnote) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+601,806$75,226→ 601,806 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (601,806 underlying) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+201,929$25,241→ 201,929 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (201,929 underlying) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+98,973$12,372→ 98,973 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (98,973 underlying) - Purchase
Common Stock
2023-05-31$2.43/sh+197,946$481,009→ 1,107,370 total(indirect: See footnote) - Purchase
Common Stock
2023-05-31$2.43/sh+1,203,612$2,924,777→ 2,521,745 total(indirect: See footnote)
North Bridge Venture Partners VI L P
10% Owner
Transactions
- Purchase
Common Stock
2023-05-31$2.43/sh+403,858$981,375→ 2,259,301 total(indirect: See footnote) - Purchase
Common Stock
2023-05-31$2.43/sh+197,946$481,009→ 1,107,370 total(indirect: See footnote) - Purchase
Common Stock
2023-05-31$2.43/sh+1,203,612$2,924,777→ 2,521,745 total(indirect: See footnote) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+98,973$12,372→ 98,973 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (98,973 underlying) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+201,929$25,241→ 201,929 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (201,929 underlying) - Purchase
Warrant to purchase Common Stock
2023-05-31$0.13/sh+601,806$75,226→ 601,806 total(indirect: See footnote)Exercise: $2.67From: 2023-11-30Exp: 2028-11-30→ Common Stock (601,806 underlying)
Footnotes (4)
- [F1]The reportable securities were acquired pursuant to the Securities Purchase Agreement dated May 25, 2023 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors.
- [F2]The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of Edward T. Anderson ("Anderson"), a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F3]The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F4]The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001138399
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:15 PM ET
- Size
- 28.4 KB